Researchers at the University of Pittsburgh Cancer Institute (UPCI) are currently studying a new way to kill cancer cells using Dynamin-related protein 1 (Drp1) knock down.

Watch Bennett Van Houten, PhD, the Richard M. Cyert Professor of Molecular Pharmacology at UPCI, discuss the progress of this study.